AI-generated summary
The authors randomized 50 inpatients with severe major depressive disorder to venlafaxine alone or venlafaxine plus 60 minutes of bright light therapy each morning for 8 weeks. The authors report that both strategies improved depression scores, with the combination showing significantly lower depression scores after week 2 and more patients reaching mild depression by week 4. They note the sample was small and that larger, longer studies are needed.
- Participants
- 50
- Who or what was studied
- Inpatients with severe major depressive disorder at a psychiatry clinic in Turkey
- Limits stated in the abstract
- The authors state the sample was small, the 8-week follow-up was short, and the 8-week difference in remission was not statistically significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on psychiatrist.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression, Trial registration, Primary outcome, Phototherapy, Anxiety, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.